| Literature DB >> 28848800 |
Pedro Russo1, Mariana Costa1, Mário Silva1, Ary de Sousa2, Diana Carvalho1, Joana Saiote1, Milena Mendes3.
Abstract
The continuous delivery of a levodopa/carbidopa gel suspension (Duodopa®) into the small bowel through a jejunal tube inserted via percutaneous endoscopic gastrostomy represents a new treatment method in advanced Parkinson disease. Some severe device-related complications have been described in the last few years. Some of them are associated with phytobezoar formation at the pigtail of the catheter. We present the case of a Parkinson disease patient treated with the Duodopa infusion system complicated by jejunal tube fistulization into the colon. We suggest a possible treatment strategy for this complication, which has not been described in the literature to date.Entities:
Keywords: Antiparkinson agents; Gastrointestinal endoscopy; Gastrostomy/adverse effects; Parkinson disease
Year: 2017 PMID: 28848800 PMCID: PMC5553370 DOI: 10.1159/000452694
Source DB: PubMed Journal: GE Port J Gastroenterol ISSN: 2387-1954